StratGraph
Companies / Utilities
SRE

Sempra

Multi-Utilities

Multi-UtilitiesAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health35
Growth29
Profitability66
Cash generation0
Balance sheet24
Dilution control59
Key ratios and five-year financials
Latest quarter revenue YoY (2026-03-31)-6.9%Revenue growth (FY)5.1%Revenue CAGR (3y)-3.3%Gross margin—Operating margin—Net margin14.8%Free cash flow margin-48.7%R&D / revenue—Stock comp / revenue0.5%Net debt / operating cash flow7.25xCurrent ratio1.59Diluted share count change2.5%
Fiscal year endingFY 2021-12FY 2022-12FY 2023-12FY 2024-12FY 2025-12
Revenue$11.7B$13.7B$14.8B$11.8B$12.4B
Net income$1.3B$2.1B$3.1B$2.9B$1.8B
Operating cash flow$3.8B$1.1B$6.2B$4.9B$4.6B
Capital expenditure$5.0B$5.4B$8.4B$8.2B$10.6B
Free cash flow-$1.2B-$4.2B-$2.2B-$3.3B-$6.0B
Stock-based comp$63M$71M$80M$86M$64M
Buybacks$339M$478M$32M$43M$58M
Dividends$1.3B$1.4B$1.5B$1.5B$1.6B
Cash$559M$370M$236M$1.6B$29M
Total debt$24.5B$27.9B$30.1B$33.6B$33.1B
Equity$26.0B$27.1B$28.7B$31.2B$31.6B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.